Form 4: Procept BioRobotics EVP, CFO Kevin Waters Sells Shares to Cover Tax Obligations
SEC Form 4
Kevin Waters, EVP and CFO of Procept BioRobotics Corp, sold 1,024 shares of common stock on March 18, 2024, to cover tax withholding obligations related to vesting Restricted Stock Units.
Summary
- On March 18, 2024, Kevin Waters, the EVP and CFO of Procept BioRobotics Corp, sold 1,024 shares of the company's common stock.
- The sale was executed at a weighted average price of $48.83 per share.
- The transaction was conducted to cover tax withholding obligations associated with the vesting of Restricted Stock Units (RSUs) granted on March 31, 2022.
- Following the transaction, Waters directly owns 102,149 shares of Procept BioRobotics Corp.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine transaction to cover tax obligations, not necessarily indicative of a positive or negative outlook.
Industry Context
This is a routine Form 4 filing, indicating insider activity. It is common for executives to sell shares to cover tax obligations when RSUs vest. The sale itself doesn't necessarily indicate a negative outlook on the company.
Stakeholder Impact
- The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 03/31/2022 | Date of grant for the Restricted Stock Units (RSUs). |
| 03/18/2024 | Date of the transaction (sale of shares). |
| 03/20/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.